Process Development CDMOs
184 published
184 published CDMOs match Process Development.
Locations in this set include United States, United Kingdom, India, China, Germany, and France.
Capabilities that show up most often in this set: Small Molecule, Biologics (Other), Biologics (Monoclonal Antibodies), Gene Therapy, and Cell Therapy.
Matching companies
Siegfried HoldingGlobal CDMO with 16 production sites across four continents, offering integrated development and manufacturing from early-phase to commercial scale for drug substance and drug product.
Sinopep-Allsino Biopharmaceutical Co., Ltd.GMP peptide and oligonucleotide CDMO offering custom synthesis, NCE development, CMC manufacturing, and finished dosage form formulation services for therapeutic programs.
Sophia CDMOEuropean CDMO specializing in microbial and precision fermentation up to 40,000 L across two integrated sites (Pamplona, Spain and Basel, Switzerland), with core strengths in E. coli expression, animal health biologics, probiotics, and complex CMC programs requiring scale-up discipline and impurity control.
Sparge Chem Pvt. Ltd.Pune-based provider of custom synthesis, medicinal chemistry, process development, and CRAMS/CDMO services for drug discovery and API intermediates. Offers FTE and fee-for-service engagement models with a 24-hour feasibility response.
Sterling Pharma SolutionsSmall molecule CDMO offering comprehensive API development and manufacturing from discovery through commercial cGMP production, with specialized expertise in complex and hazardous chemistries and ADC bioconjugation.
Sussex Research Laboratories Inc.Global leader in carbohydrate and glycan synthesis, offering custom synthesis, CRO, and CDMO services for drug discovery and development. Specializes in GalNAc targeting ligands, glycopeptides, and glycoconjugates with over 25 years of expertise.
Symbiosis Pharmaceutical ServicesUK-based fill-finish CDMO offering rapid access to GMP aseptic manufacturing for clinical and commercial injectable drug products across mAbs, ATMPs, ADCs, RNA, peptides, vaccines, and small molecules.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
SynthegoSynthego manufactures GMP-grade CRISPR components and molecular biology reagents for clinical and research applications, with 19 INDs cleared and 200+ clinical sgRNA batches produced.
TriLink BioTechnologiesTriLink manufactures mRNA, oligonucleotides, and modified nucleotides with proprietary CleanCap® capping technology achieving >95% Cap1 efficiency, supported by in-house analytical method development and a 118,000 sq ft GMP-capable facility.
UPM PharmaceuticalsIndependent, family-owned CDMO specializing in oral solids, semi-solids, and controlled-substance manufacturing with 475,000 sq ft cGMP facility in Bristol, TN; over 80 products commercialized.
Unither PharmaceuticalsGlobal CDMO specializing in sterile and non-sterile liquid manufacturing, including Blow-Fill-Seal (BFS) single-dose technology with over 5 billion annual capacity, plus formulation development, analytical services, and ophthalmic expertise across six production sites.
ValidogenVALIDOGEN provides Pichia pastoris strain development and fermentation process development services for recombinant protein manufacturing, with proven scale-up to 200,000 L and titers up to 45 g/L.
VeranovaGlobal CDMO specializing in development and manufacturing of complex active pharmaceutical ingredients (APIs), with expertise in solid form sciences, process development, and specialty modalities including ADCs and controlled substances.
Vernal BiosciencesVernal Biosciences is a leading mRNA CDMO providing high-purity mRNA, LNP formulation, process development, GMP manufacturing, and analytical testing for vaccines, gene therapies, and mRNA therapeutics.
Vetter PharmaIndependent CDMO specialist in aseptic fill-finish, drug product development, analytical services, and combination product assembly with 76 years of experience and 7,300+ employees globally.
Wheeler BioOklahoma-based CDMO specializing in antibody-based therapeutics from cell line development through cGMP manufacturing. Offers ModularCMC platform with phase-appropriate work packages and high-touch project management.
Winkem Labs Pvt. Ltd.Contract development and manufacturing organization (CDMO) offering complex chemical synthesis, process development, API manufacturing, and supply services for pharmaceutical clients globally.
WuXi BiologicsGlobal biologic CDMO offering end-to-end solutions from discovery to commercialization.
WuXi VaccinesGlobal CDMO specializing in end-to-end vaccine and prophylactic antibody development and manufacturing across mammalian, viral, and microbial platforms with GMP-certified facilities and over 550 million doses delivered.
Markdown mirror: /services/process-development.md